These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Author: Saffar MJ, Alraza-Amiri M, Ajami A, Baba-Mahmoodi F, Khalilian AR, Vahidshahi C, Shamsizadeh A.
    Journal: East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796.
    Abstract:
    We evaluated the seroprevalence of measles antibody and response to measles reimmunization in 590 previously vaccinated adolescents and young adults; 263 were seronegative. To differentiate between primary and secondary vaccine failure, anti-measles IgM and IgG titres were assessed again 2-4 weeks after revaccination in 144 (105 seronegative, 39 seropositive) individuals: 75 seronegative participants responded to revaccination anamnestically (P < 0.001) and developed immunity, 11 also showed IgM response (probably primary vaccine failure); 38 seropositive participants remained seroprotected without significant increase in antibody titre (P = 0.577). Primary vaccine failure was 4.7%; secondary vaccine failure was 27.1%. After revaccination, 87.3% were seroprotected.
    [Abstract] [Full Text] [Related] [New Search]